Genuity Capital Markets
http://www.genuitycm.com/Genuity Capital Markets is a financial services firm providing investment banking, institutional sales and trading, and equity research to its corporate clients. The firm uses a simple Buy, Hold and Sell rating system in its research analysis.
View Older Stories View More Recent Stories
-
Canaccord Genuity Reiterates a 'Hold' on Jacobs Engineering (JEC); Q4/F10 Results and F2011 Guidance In Line
-
Canaccord Genuity maintains a 'Buy' on Atheros Communications (ATHR); Increasing Rstimates on Stable PCs, Strong Product Cycles
-
Canaccord Genuity Maintains a 'Buy' on Vale S.A. (VALE); Valuation Update
-
Canaccord Genuity Morning Coffee on Wal-Mart (WMT): Hitting The Wall
-
Canaccord Genuity Morning Coffee on United Parcel Service (UPS): The Happiest Time of Year
-
Canaccord Genuity Morning Coffee on Target (TGT): Right On
-
Canaccord Genuity Morning Coffee on Juniper Networks (JNPR): In Trapeze News...
-
Canaccord Genuity Morning Coffee on Home Depot (HD): Frank the Tank's Favourite Home-Improvement Store!
-
Canaccord Genuity Morning Coffee on Dick's Sporting Goods (DKS): You Bet He Is
-
Canaccord Genuity Initiates Coverage on Life Sciences – Biomedical Devices and Services Stocks
-
Canaccord Genuity Morning Coffee on Sirius XM Radio (SIRI)
-
Canaccord Genuity Morning Coffee on Lowes Companies (LOW): Hammer Time
-
Canaccord Genuity Morning Coffee on HeartWare (HTWR) and Thoratec (THOR): Starts Off With a Vang
-
Canaccord Genuity Morning Coffee on Apple (AAPL): It doesn't get better than this
-
Canaccord Genuity Reiterates a 'Buy' on RTI Biologics (RTIX); Direct Distribution and New Products to Provide Consistency and Growth
-
Canaccord Genuity maintains a 'Hold' on Edwards Lifesciences (EW); Strong TAVI Quality-of-Life Data
-
Canaccord Genuity Maintains a 'Hold' on Motorola (MOT); Separation on Track for January 2011
-
Canaccord Genuity Reiterates a 'Buy' on Ultimate Software (ULTI); Valuation Matters and in Fact, ULTI is Relatively Inexpensive
-
Canaccord Genuity Upgrades Compellent Technologies (CML) to Hold; on Risk/Reward
-
Canaccord Genuity maintains a 'Buy' on Nexen Inc. (NXY); 011 Production/Capex Guidance + COSun Read-through
-
Canaccord Genuity Starts Meridian Biosciences (VIVO) at Hold, Price Target $21
-
Canaccord Genuity Starts Becton Dickinson (BDX) at Hold, Price Target $85
-
Canaccord Genuity Starts AspenBio Pharma (APPY) at Hold, Price Target $0.50
-
Canaccord Genuity Starts Beckman Coulter (BEC) at Hold, Price Target $52
-
Canaccord Genuity Starts Genomic Health Inc. (GHDX) at Hold, Price Target $19
-
Canaccord Genuity Starts Quidel Corp. (QDEL) at Buy, Price Target $18
-
Canaccord Genuity Starts OraSure Technologies (OSUR) at Buy, Price Target $8
-
Canaccord Genuity Starts Gen-Probe (GPRO) at Buy, Price Target $59
-
Canaccord Genuity Starts Cepheid (CPHD) at Buy, Price Target $27
-
Canaccord Genuity Starts Cepheid (CPHD) at Buy, Price Target $27
-
Canaccord Genuity Starts Alere (ALR) at Buy, Price Target $40
-
Canaccord Genuity Upgrades Compellent Technologies (CML) to Hold, Price Target $27.50
-
Canaccord Genuity Reiterates a 'Buy' on Optimer Pharmaceuticals (OPTR); 2011 Should Bring US and EU Fidaxo Approvals
-
Canaccord Genuity Maintains a 'Hold' on Cardiome Pharma (CRME); Q3 Results: Updates Expected Before Year-End
-
Canaccord Genuity maintains a 'Buy' on Telvent GIT (TVLT); Q3 Preview: Blocking & Tackling Into 2011
-
Notable Analyst Rating Changes 11/15: SNV, HTWR, CL, JCG Upgraded; LLNW, THOR, AKAM, RAX Downgraded
-
Canaccord Genuity on G20 Meeting: Can’t We Just Agree to Felay?
-
Canaccord Genuity Morning Coffee on Wendy's/Arby's Group (NYSE: WEN): Quick, Let's Whip Up Some Frappes
-
Canaccord Genuity Morning Coffee on Intel (INTC): Dividend-astic
-
Canaccord Genuity Morning Coffee on Dynegy (DYN): Icahn Never Bluffs
-
Canaccord Genuity Morning Coffee on DR Horton (NYSE: DHI): Flattened Homes
-
Canaccord Cuts RINO International (RINO) to Sell Amid Q3 Miss
-
Canaccord Genuity on Life Sciences -- Biomedical Devices and Services: Stellar HVAD BTT Data at AHA - Implications for HTWR and THOR
-
Canaccord Genuity Maintains a 'Sell' Rating on SunPower (SPWRA); Strong Quarter, but Shares Could Underperform in 2011 on Valuation Model Risks
-
Canaccord Genuity Maintains a 'Hold' on ESCO Technologies (ESE); Upside as Advertised
-
Canaccord Genuity Reiterates a 'Buy' on AECOM Technology (ACM); Designs on iimpressive 2011 EPS Growth
-
Canaccord Genuity Reiterates a 'Buy' on Ceragon Networks (CRNT); Steady Growth, Improving Profitability in 2011
-
Canaccord Genuity Reiterates a 'Buy' on Smith Micro Software (SMSI); Building a Platform for Longer-term Growth
-
Canaccord Genuity Reiterates a 'Buy' on Sierra Wireless (SWIR); Secular Trends Drive Longer-Term Earnings Growth
-
Canaccord Genuity Reiterates a 'Buy' Rating on NVIDIA (NVDA) Ahead of Tegra Ramp
